$XERS

$10.21 +$0.01 (0.1%) Close

$XERS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 182.3M shares outstanding

Who owns XERS?

By type of holder

Institutions 59.1% Insiders 5.2% Everyone else 35.7%

Concentration Top 10 holders own 30.1%

BlackRock, Inc. 8.0% · D. E. Shaw & Co., Inc. 4.3%

Institutional ownership

59.1%

+1.6 pts vs last qtr

Institutional holders

237

+1 vs last qtr

Net shares bought

+2.8M

by institutions in Q2 2026

New / sold out

34 / 33

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +1.6M
Nuveen, LLC +1.5M

Biggest sellers in Q2 2026

Millennium Management LLC −2.1M
Voss Capital, LP SOLD OUT −1.4M

Who is planning to sell?

Notices of proposed sale, last 12 months

$5.94M

18 notices from 10 people

Shares covered

790.9K

0.43% of the company

Arranged in advance

84%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Kevin Mcculloch Officer 10b5-1 $2.02M
Beth Hecht Officer 10b5-1 $1.48M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+118.6%

+21.59% a year

Each share's claim on the business

−54.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $75M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years59% 1–3 years25% Under 1 year16%

Quarterly turnover

14.0%

of institutional shares changed hands

Top 10 managers, median time held

4.5 years

Super Investors

Investment managers reporting XERS on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	14.5M	7.97%	+1.6M (+12.2%)	2021	0.0%
Shares held by quarter Peak holding14.5M (Q2'26) Change over 8 quarters+3.8M Share of the company7.970% BlackRock, Inc.'s full portfolio →
DE D. E. Shaw & Co., Inc.	7.8M	4.28%	+15.9K (+0.2%)	2022	0.0%
Shares held by quarter Peak holding7.8M (Q2'26) Change over 8 quarters+6.8M Share of the company4.280% D. E. Shaw & Co., Inc.'s full portfolio →

BlackRock, Inc.

14.5M

% of company

7.97%

Change vs last qtr

+1.6M (+12.2%)

Held since

2021

D. E. Shaw & Co., Inc.

7.8M

% of company

4.28%

Change vs last qtr

+15.9K (+0.2%)

Held since

2022

28 more super investors behind a free account

See every manager holding Xeris Biopharma Holdings Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting XERS on Form N-PORT; together they hold 21.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$41.1M	5.2M	2.85%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$35.3M	4.5M	2.44%	0.04%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$41.1M

% of company

2.85%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$35.3M

% of company

2.44%

% of the fund

0.04%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Xeris Biopharma Holdings Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
SJ Shannon John Patrick Jr Insider	2.9M	1.59%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.590% Shannon John Patrick Jr's insider activity →
MK McCulloch Kevin Insider	1.6M	0.89%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.890% McCulloch Kevin's insider activity →

Shannon John Patrick Jr

Insider

2.9M

% of company

1.59%

Change vs last qtr

—

Held since

—

McCulloch Kevin

Insider

1.6M

% of company

0.89%

Change vs last qtr

—

Held since

—

12 more holders behind a free account

See every insider and 5%+ holder of Xeris Biopharma Holdings Inc.

Comments